— Know what they know.
Not Investment Advice

NSTM OTC

NovelStem International Corp.
1W: -2.5% 1M: +5.3% 3M: +0.0% YTD: +0.0% 1Y: -66.7% 3Y: -95.0% 5Y: -96.2%
$0.01
+0.00 (+0.00%)
 
OTC · Healthcare · Medical - Diagnostics & Research · Tech Score Sell · Power 37 · $493325 mcap · 14M float · 0.146% daily turnover · Short 53% of daily vol

Balance Sheet Trends

Total Assets
$16K -90.1% ▼
5Y CAGR: -66.2%
Total Liabilities
$2M -59.3% ▼
5Y CAGR: +99.2%
Shareholders Equity
-$2M +58.4% ▲
Cash & Investments
$333 -94.5% ▼
5Y CAGR: -67.3%
Total Debt
$2M -60.8% ▼
Net Debt
$2M -60.8% ▼

Assets vs Liabilities & Equity

Year-over-Year Growth

View Full Balance Sheet
Line ItemFY2021FY2022FY2023FY2024FY2025
— Assets —
Cash$9K$6K$53K$6K$333
Short-Term Investments$0$0$0$0$0
Cash & ST Investments$9K$6K$53K$6K$333
Net Receivables$0$12K$0$10K$0
Inventory$0$0$0$0$0
Other Current Assets$0$0$0$0$0
Total Current Assets$37K$59K$87K$32K$16K
Property, Plant & Equip.$0$23K$0$0$0
Goodwill & Intangibles$0$0$0$0$0
Long-Term Investments$3M$2M$2M$128K$0
Other Non-Current Assets$0-$23K$250K$0$0
Total Non-Current Assets$3M$2M$2M$128K$0
Total Assets$3M$2M$2M$160K$16K
— Liabilities —
Accounts Payable$50K$21K$54K$168K$216K
Short-Term Debt$100K$0$250K$4M$2M
Deferred Revenue$0$0$0$0$0
Other Current Liabilities$0$0$0$650K$216K
Total Current Liabilities$193K$65K$346K$5M$2M
Long-Term Debt$0$288K$3M$0$0
Other Non-Current Liab.$0$0$535K$0$210K
Total Non-Current Liabilities$0$288K$4M$0$210K
Total Liabilities$193K$353K$4M$5M$2M
— Equity —
Common Stock$469K$469K$469K$469K$469K
Retained Earnings-$288M-$289M-$293M-$296M-$294M
Accumulated OCI$0$0$0$0$0
Total Stockholders Equity$2M$2M-$2M-$5M-$2M
Total Liabilities & Equity$3M$2M$2M$160K$16K
— Key Metrics —
Total Debt$100K$288K$4M$4M$2M
Net Debt$91K$282K$4M$4M$2M
Total Investments$3M$2M$2M$128K$0

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms